HOME >> BIOLOGY >> NEWS
Early promise for treatment of Ebola

Preliminary findings of an animal study in this week's issue of THE LANCET suggest that scientists have taken an important step towards a possible treatment strategy for the deadly Ebola virus.

Haemorragic fever from the Ebola virus is fatal in up to 80%of cases in humans. The virus is thought to cause excessive blood coagulation and thrombosis leading to organ dysfunction. Inhibition of the blood coagulation pathway could therefore be a potential therapeutic approach for ebola treatment.

Thomas W Geisbert from the US Army Medical Research Institute of Infectious Diseases and colleagues injected 12 rhesus macaques with the ebola virus to induce the deadly ebola haemorragic fever. Nine of the macaques received an inhibitor of the blood coagulation pathway (called recombinant nematode anticoagulant protein c2, rNAPc2), while three macaques received the ebola virus only (the control group).

Treatment with rNAPc2 prolonged survival time and resulted in a 33% survival rate; this contrasted with macaques in the control group, of whom all except one died (since the study was completed the remaining control animal has also died). The surviving macaques in the treatment group were in good health nine months after the study. Survival was longer (12 days) for treated macaques who died compared with untreated macaques in the control group (8 days).

Thomas W Geisbert comments: "Our results have great clinical implications, since our treatment approach of Ebola haemorrhagic fever targets the disease process rather than replication of the infectious agent. Moreover, our findings raise the possibility that rNAPc2 could be useful in the treatment of other viral haemorrhagic fevers. Importantly, rNAPc2 has a suitable phamacokinetic and safety profile in human beings. The clinical efficacy of this treatment modality now needs to be proven."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
11-Dec-2003


Page: 1

Related biology news :

1. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
2. Early detection hope for eye disease
3. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
4. Early dexamethasone exposure has long-term neurodevelopment, neuroendocrine effects
5. Early predictor of breast cancer aggressiveness
6. Early treatment confirmed as key to stroke recovery
7. Early identification of kidney disease cost-effective only when directed at high-risk patients
8. Early treatment can prevent severe vision loss in premature infants
9. Early hominids may have behaved more human than we had thought
10. Early infection and rejection detection
11. Early-life environments shape development of stress behaviors and learning abilities in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/30/2019)... (PRWEB) , ... January 30, ... ... organization that identifies, counsels, and supports high-growth, high-impact life science and biotechnology ... representing 10 national nonprofit disease foundations and disease-focused venture funds to discuss ...
(Date:1/25/2019)... ... January 24, 2019 , ... ... its 2019 Association Industry Survey. The report indicates membership growth in some sectors ... to early December 2018, received responses from over 500 association professionals across North ...
(Date:1/24/2019)... ... January 23, 2019 , ... rHEALTH ... a Notice of Allowance from the United States Patent and Trademark Office (USPTO) ... company, DNA Medicine Institute (DMI). This application covers the addition of a length ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... Rico (PRWEB) , ... January 29, 2019 , ... K&R ... the featured expert at a special online event titled: Six Ways to Shorten ... p.m. eastern time, February 13, 2019 on the BrightTALK network. , Negotiation expert ...
(Date:1/30/2019)... , ... January 30, 2019 , ... ... of the international tasting 5StarWines to promote and give recognition to producers whose ... Wine Without Walls selection takes place in Verona, Italy, contemporaneously to the 5StarWines ...
(Date:1/24/2019)... ... January 22, 2019 , ... Outsourcing trials ... own set of assumptions, and RFP creation and management generally requires manual effort. ... comparing apples to oranges. These challenges can ultimately lead to study start delays ...
(Date:1/20/2019)... ... January 17, 2019 , ... Consumers are directing ... purview of physicians. That's changing as many services now exist for patients to ... testing market totaled $208 million in 2018, according to Kalorama Information’s new report, ...
Breaking Biology Technology:
Cached News: